Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 6
2005 2
2006 6
2007 1
2008 5
2009 2
2010 4
2011 6
2012 4
2013 6
2014 2
2015 5
2016 10
2017 5
2018 5
2019 10
2020 8
2021 15
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. Among authors: benedetti f. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Beelen DW, Stelljes M, Reményi P, Wagner-Drouet EM, Dreger P, Bethge W, Ciceri F, Stölzel F, Junghanß C, Labussiere-Wallet H, Schaefer-Eckart K, Grigoleit GU, Scheid C, Patriarca F, Rambaldi A, Niederwieser D, Hilgendorf I, Russo D, Socié G, Holler E, Glass B, Casper J, Wulf G, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, La Rocca U, Finke J, Benedetti F, Pichlmeier U, Klein A, Baumgart J, Markiewicz M. Beelen DW, et al. Among authors: benedetti f. Am J Hematol. 2022 Aug;97(8):1023-1034. doi: 10.1002/ajh.26620. Epub 2022 Jun 8. Am J Hematol. 2022. PMID: 35617104 Free article. Clinical Trial.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Beelen DW, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet EM, Hauptrock B, Dreger P, Luft T, Bethge W, Vogel W, Ciceri F, Peccatori J, Stölzel F, Schetelig J, Junghanß C, Grosse-Thie C, Michallet M, Labussiere-Wallet H, Schaefer-Eckart K, Dressler S, Grigoleit GU, Mielke S, Scheid C, Holtick U, Patriarca F, Medeot M, Rambaldi A, Micò MC, Niederwieser D, Franke GN, Hilgendorf I, Winkelmann NR, Russo D, Socié G, Peffault de Latour R, Holler E, Wolff D, Glass B, Casper J, Wulf G, Menzel H, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, Grass S, Iori AP, Finke J, Benedetti F, Pichlmeier U, Hemmelmann C, Tribanek M, Klein A, Mylius HA, Baumgart J, Dzierzak-Mietla M, Markiewicz M. Beelen DW, et al. Among authors: benedetti f. Lancet Haematol. 2020 Jan;7(1):e28-e39. doi: 10.1016/S2352-3026(19)30157-7. Epub 2019 Oct 9. Lancet Haematol. 2020. PMID: 31606445 Clinical Trial.
E2F1 as a molecular drug target in ovarian cancer.
Farra R, Dapas B, Grassi M, Benedetti F, Grassi G. Farra R, et al. Among authors: benedetti f. Expert Opin Ther Targets. 2019 Mar;23(3):161-164. doi: 10.1080/14728222.2019.1579797. Epub 2019 Feb 8. Expert Opin Ther Targets. 2019. PMID: 30724632 No abstract available.
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors.
Calzetti F, Finotti G, Tamassia N, Bianchetto-Aguilera F, Castellucci M, Canè S, Lonardi S, Cavallini C, Matte A, Gasperini S, Signoretto I, Benedetti F, Bonifacio M, Vermi W, Ugel S, Bronte V, Tecchio C, Scapini P, Cassatella MA. Calzetti F, et al. Among authors: benedetti f. Nat Immunol. 2022 May;23(5):679-691. doi: 10.1038/s41590-022-01189-z. Epub 2022 Apr 28. Nat Immunol. 2022. PMID: 35484408
Machine learning techniques to characterize functional traits of plankton from image data.
Orenstein EC, Ayata SD, Maps F, Becker ÉC, Benedetti F, Biard T, de Garidel-Thoron T, Ellen JS, Ferrario F, Giering SLC, Guy-Haim T, Hoebeke L, Iversen MH, Kiørboe T, Lalonde JF, Lana A, Laviale M, Lombard F, Lorimer T, Martini S, Meyer A, Möller KO, Niehoff B, Ohman MD, Pradalier C, Romagnan JB, Schröder SM, Sonnet V, Sosik HM, Stemmann LS, Stock M, Terbiyik-Kurt T, Valcárcel-Pérez N, Vilgrain L, Wacquet G, Waite AM, Irisson JO. Orenstein EC, et al. Among authors: benedetti f. Limnol Oceanogr. 2022 Aug;67(8):1647-1669. doi: 10.1002/lno.12101. Epub 2022 Jun 30. Limnol Oceanogr. 2022. PMID: 36247386 Free PMC article. Review.
Strategies for Delivery of siRNAs to Ovarian Cancer Cells.
Farra R, Maruna M, Perrone F, Grassi M, Benedetti F, Maddaloni M, El Boustani M, Parisi S, Rizzolio F, Forte G, Zanconati F, Cemazar M, Kamensek U, Dapas B, Grassi G. Farra R, et al. Among authors: benedetti f. Pharmaceutics. 2019 Oct 22;11(10):547. doi: 10.3390/pharmaceutics11100547. Pharmaceutics. 2019. PMID: 31652539 Free PMC article. Review.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai SV, Castellino C, Stefoni V, Pinto A, Zanni M, Ciancia R, Ghiggi C, Rossi FG, Arcari A, Ilariucci F, Zilioli VR, Flenghi L, Celli M, Volpetti S, Benedetti F, Ballerini F, Musuraca G, Bruna R, Patti C, Leonardi F, Arcaini L, Magagnoli M, Cavallo F, Bermema A, Tucci A, Boccomini C, Ciccone G, Carniti C, Pileri SA, Corradini P. Chiappella A, et al. Among authors: benedetti f. Leukemia. 2023 Feb;37(2):433-440. doi: 10.1038/s41375-022-01780-1. Epub 2023 Jan 18. Leukemia. 2023. PMID: 36653509 Free PMC article. Clinical Trial.
108 results